Clear Street’s BioCardia, Inc. Warrant BCDAW Stock Holding History

Clear Street’s Portfolio BCDAW Stock Details BCDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$1	–	844
2024 Q2	$1	Buy	+100	New	+$2	﹤0.01%	810

Clear Street's BCDAW Position: Q3 2024 in Review

Clear Street sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2024, closing a stake of 100 shares — an estimated $1 sold.

Clear Street first reported a position in BCDAW in Q2 2024 and held it in 1 quarter. The position peaked at $1 in Q2 2024. 0 funds tracked by Wall St. Rank hold BCDAW as of Q3 2024.

Clear Street reported no remaining BioCardia, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Clear Street sold 100 BioCardia, Inc. Warrant shares in Q3 2024, an estimated $1.
Clear Street first reported a position in BioCardia, Inc. Warrant in Q2 2024 and held it in 1 quarter.
Clear Street's BioCardia, Inc. Warrant position peaked at $1 in Q2 2024.
0 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2024.

Based on Clear Street's 13F filing for Q3 2024, filed 14 Nov 2024.